 |

Ocular
Microbiology and Immunology Group
Back
to OMIG Main Page
< Previous | 2026 Agenda and Abstracts | Next >
2026 OMIG Abstract
Infectious Keratitis Isolates and Susceptibility in the Pacific Northwest
LuAnna Rochelle2, Alexa Watson2, Emilia Hommestaad1, Ryan Liao1, Leona Ding3, Andrew Chen3,
Shu Feng3, Miel Sundararajan3, and Minh Nguyen3
1University of Washington, Seattle, Washington; 2University of Washington School of Medicine, Seattle, Washington; 3Department of Ophthalmology, University of Washington School of Medicine, Seattle, Washington
Purpose: To examine causative microorganisms and antibiotic susceptibility profiles of culture-positive infectious keratitis in the Pacific Northwest over an 11-year period.
Methods: This retrospective study reviewed medical records identified by diagnosis codes for microbial keratitis from January 1, 2014, to December 31, 2024, at the University of Washington. Cases of viral keratitis were excluded. Prevalence, antibiotic susceptibility, and yearly trends were analyzed.
Results: A total of 443 microbial isolates where identified. Of these, 380 (85.8%) were bacteria, 47 (10.6%) were fungi, and 16 (3.6%) were Acanthamoeba. The most common bacterial species was Staphylococcus (n = 96, 25%), and the most common gram-negative was Pseudomonas (n = 63, 16.5%). Among fungi, Candida was the most common (n = 15, 33%). Bacterial isolates showed a meaningful decrease in the relative proportion year after year (B = -0.015, P < 0.001, 95% CI [-0.020, -0.009]). However, both fungi and Acanthamoeba showed a significant increase in proportion each year (fungi: B = 0.009, P = 0.012, 95% CI [0.002, 0.015]; Acanthamoeba: B = 0.006, P = 0.012, 95% CI [0.002, 0.010]). Fifty-one percent (n = 37 / 72) of Staphylococcus isolates showed resistant to erythromycin.
Conclusions: Microbial keratitis in the Pacific Northwest is most commonly caused by bacteria. However, there was a meaningful increase in fungal and Acanthamoeba cases. As a result, clinicians in this region should maintain a high index of suspicion for these pathogens and pursue early diagnostic testing. Use of erythromycin for empiric treatment warrants further inspection.
Disclosure: N
< Previous | 2026 Agenda and Abstracts | Next >
|

|